ClinicalThought

Share

Program Content

Activities

  • BTK Inhibitors in CLL
    My Perspective on 3 Questions I Am Asked on BTK Inhibitors for CLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 16, 2020

    Expires: November 15, 2021

  • BTKi in CLL: FAQ
    Expert Answers to Frequently Asked Questions on BTK Inhibitors for Treatment of CLL
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 15, 2021

    Expires: January 14, 2022

Faculty

cover img faculity

Ian W. Flinn, MD, PhD

Chief Scientific Officer
One Oncology and Tennessee Oncology
Nashville, Tennesse

cover img faculity

Susan M. O Brien, MD

Professor of Medicine
Department of Leukemia
University of Texas M.D. Anderson Cancer Center
Houston, Texas

cover img faculity

John Pagel, MD, PhD

Associate Professor
Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, Washington

Provided by

ProCE Banner

Supporters

AstraZeneca

BeiGene, Ltd.